Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report
<p>Abstract</p> <p>Introduction</p> <p>Ifosfamide is a chemotherapy agent infrequently associated with liver toxicity. To the best of our knowledge, this report is the first to describe serious liver toxicity associated with ifosfamide used in combination with doxorubic...
Main Authors: | Jones Robin L, Cheung Michelle CM, Judson Ian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | Journal of Medical Case Reports |
Online Access: | http://www.jmedicalcasereports.com/content/5/1/180 |
Similar Items
-
Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
by: Juan Martin-Liberal, et al.
Published: (2013-01-01) -
Outcome and Toxicity of an Ifosfamide-Based Soft Tissue Sarcoma Treatment Protocol in Children. The Importance of Local Therapy
by: S. Murray Yule, et al.
Published: (1998-01-01) -
Ifosfamide-induced Encephalopathy in Patients With Uterine Sarcoma
by: Shih-Hung Tsai
Published: (2010-03-01) -
Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
by: Annelies Requilé, et al.
Published: (2017-01-01) -
Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma
by: Ephraim S. Casper, et al.
Published: (1999-01-01)